Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes.

Cancer cell·2026
Same author

Reviving CD2 signaling to boost CAR T-cell therapy.

Blood·2026
Same author

Integrin-dependent neutrophil slowing reduces lung perfusion and supports metastasis in a model of breast cancer.

Cell reports·2026
Same author

Hijacked helpers: Tr1 cells fuel immune escape in B-ALL.

Blood·2025
Same author

Integrative perspectives on signaling, mechanics, and immune interactions in B-cell malignancies.

FEBS letters·2025
Same author

Longitudinal omics data and preclinical treatment suggest the proteasome inhibitor carfilzomib as therapy for ibrutinib-resistant CLL.

Nature communications·2025

Related Experiment Video

Updated: Jun 28, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

Lessons learned from the Eµ-TCL1 mouse model of CLL.

Alessia Floerchinger1, Martina Seiffert2

  • 1Department of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Biosciences of the University of Heidelberg, Heidelberg, Germany.

Seminars in Hematology
|June 5, 2024
PubMed
Summary

The Eµ-TCL1 mouse model aids chronic lymphocytic leukemia (CLL) research but has limitations. Understanding its pitfalls and successes is crucial for developing effective CLL therapies.

Keywords:
CLL biologyChronic lymphocytic leukemiaEµ-TCL1 mouse modelPreclinical treatment studyTCL1 transplantation model

More Related Videos

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Related Experiment Videos

Last Updated: Jun 28, 2026

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
12:16

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

14.7K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • The Eµ-TCL1 mouse model overexpresses TCL1, inducing a chronic lymphocytic leukemia (CLL)-like disease.
  • This model has been pivotal in understanding CLL pathobiology and testing therapies for over two decades.

Purpose of the Study:

  • To review the knowledge gained from the Eµ-TCL1 mouse model in studying chronic lymphocytic leukemia (CLL).
  • To critically assess the model's limitations and potential for future CLL research and therapeutic development.

Main Methods:

  • Review of studies utilizing the Eµ-TCL1 mouse model for CLL research.
  • Analysis of findings related to B cell receptor (BCR) signaling, tumor microenvironment, and immunotherapy.

Main Results:

  • The model was crucial for developing effective B cell receptor (BCR) signaling inhibitors, now standard CLL care.
  • Studies highlighted the importance of the tumor microenvironment and immune suppressive mechanisms in CLL progression.
  • Discrepancies in immunotherapy efficacy between the model and human trials raise questions about translatability.

Conclusions:

  • The Eµ-TCL1 model offers valuable insights into CLL biology and therapy development despite limitations.
  • Further research should address the model's shortcomings to improve the translation of preclinical findings to clinical practice.
  • Optimizing the use of this model is essential for advancing towards a cure for chronic lymphocytic leukemia (CLL).